Ballal Rahul D.
SEC insider (Form 3/4/5 filer). CIK 0001805097. Director at AGIOS PHARMACEUTICALS, INC. (AGIO) and 1 other issuer. 19 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in CAMBRIDGE, MA.
Companies Ballal Rahul D. has filed insider reports for
- AGIOS PHARMACEUTICALS, INC. (AGIO): Director
- Enliven Therapeutics, Inc. (ELVN): Director
Ballal Rahul D.
CIK: 0001805097
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
2.9K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2.8K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
15K shares- - Feb 12, 2026ELVN
Enliven Therapeutics, Inc.
AwardDirectStock Option (right to buy)
17.1K shares- - Aug 11, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2.3K shares- - Jun 20, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2.1K shares- - Jun 18, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
15.8K shares- - Jun 18, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
2.8K shares- - Feb 6, 2025ELVN
Enliven Therapeutics, Inc.
AwardDirectStock Option (right to buy)
20.5K shares- - Nov 8, 2024AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect1.5K shares at avg. $59.21$89K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 2,927 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 2,816 | - | $0 | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 14,950 | - | - | Direct |
| Feb 12, 2026 |  ELVN Enliven Therapeutics, Inc. | Award Stock Option (right to buy) | 17,126 | - | - | Direct |
| Aug 11, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 2,302 | - | - | Direct |
| Jun 20, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 2,120 | - | - | Direct |
| Jun 18, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 15,768 | - | - | Direct |
| Jun 18, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 2,816 | - | - | Direct |
| Feb 6, 2025 | ELVN Enliven Therapeutics, Inc. | Award Stock Option (right to buy) | 20,491 | - | - | Direct |
| Nov 8, 2024 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 1,500 | $59.21 | $88,815 | Direct |
1-10 of 19 transactions